CA2385745C
(en)
|
2001-06-08 |
2015-02-17 |
Abbott Laboratories (Bermuda) Ltd. |
Methods of administering anti-tnf.alpha. antibodies
|
BR0212136A
(pt)
|
2001-08-23 |
2004-12-07 |
Genmab As |
Anticorpo monoclonal humano isolado, métodos para inibir a produção de tnfa em células t ou monócitos e a proliferação de célula t, hibridoma, transfectoma, animal não humano transgênico, método para produzir um anticorpo monoclonal humano, composição farmacêutica, métodos para tratar ou prevenir um distúrbio mediado pela il-15 humana, a psorìase e a artrite reumatóide, método para diagnosticar uma doença, ácido nucleico, e, vetor de expressão
|
US7247304B2
(en)
|
2001-08-23 |
2007-07-24 |
Genmab A/S |
Methods of treating using anti-IL-15 antibodies
|
US7329405B2
(en)
|
2001-08-23 |
2008-02-12 |
Genmab A/S |
Human antibodies specific for interleukin 15 (IL-15)
|
GB0208817D0
(en)
*
|
2002-04-17 |
2002-05-29 |
European Molecular Biology Lab Embl |
Method for producing monoclonal antibodies
|
RS20050724A
(en)
*
|
2003-02-26 |
2007-11-15 |
Genmab A/S., |
Human antibodies specific for interleukin 15(il-15)
|
NZ570709A
(en)
|
2003-06-13 |
2010-04-30 |
Univ Pennsylvania |
Nucleic acid sequences encoding and compositions comprising IgE signal peptide and/or IL-15 and methods for using the same
|
US20050123542A1
(en)
*
|
2003-11-06 |
2005-06-09 |
Genmab A/S |
Methods for treating disorders involving monocytes
|
KR101370253B1
(ko)
*
|
2004-10-22 |
2014-03-05 |
암젠 인크 |
재조합 항체의 재접힘 방법
|
JP2008523132A
(ja)
*
|
2004-12-13 |
2008-07-03 |
サイトス バイオテクノロジー アーゲー |
Il−15抗原アレイとその使用法
|
NZ591701A
(en)
|
2005-05-16 |
2012-11-30 |
Abbott Biotech Ltd |
Use of tnf inhibitor for treatment of erosive polyarthritis
|
AU2006259664A1
(en)
|
2005-06-14 |
2006-12-28 |
Amgen Inc. |
Self-buffering protein formulations
|
US20070190057A1
(en)
*
|
2006-01-23 |
2007-08-16 |
Jian Wu |
Methods for modulating mannose content of recombinant proteins
|
US9605064B2
(en)
|
2006-04-10 |
2017-03-28 |
Abbvie Biotechnology Ltd |
Methods and compositions for treatment of skin disorders
|
US9399061B2
(en)
*
|
2006-04-10 |
2016-07-26 |
Abbvie Biotechnology Ltd |
Methods for determining efficacy of TNF-α inhibitors for treatment of rheumatoid arthritis
|
US20080131374A1
(en)
*
|
2006-04-19 |
2008-06-05 |
Medich John R |
Uses and compositions for treatment of rheumatoid arthritis
|
PE20081760A1
(es)
|
2007-02-09 |
2009-01-01 |
Genentech Inc |
Anticuerpos anti-robo4 y sus usos
|
EP2171451A4
(en)
*
|
2007-06-11 |
2011-12-07 |
Abbott Biotech Ltd |
METHOD FOR TREATING JUVENILIAN IDIOPATHIC ARTHRITIS
|
US20110097318A1
(en)
*
|
2007-08-31 |
2011-04-28 |
Amgen Inc. |
Solid-State Protein Formulation
|
WO2009036209A2
(en)
*
|
2007-09-14 |
2009-03-19 |
Amgen Inc. |
Homogeneous antibody populations
|
CA2701032C
(en)
|
2007-09-27 |
2021-01-26 |
Amgen Inc. |
Pharmaceutical formulations
|
WO2009064838A1
(en)
|
2007-11-15 |
2009-05-22 |
Amgen, Inc. |
Aqueous formulation of erythropoiesis stimulating protein stablised by antioxidants for parenteral administration
|
TWI468417B
(zh)
|
2007-11-30 |
2015-01-11 |
Genentech Inc |
抗-vegf抗體
|
EP2098536A1
(en)
|
2008-03-05 |
2009-09-09 |
4-Antibody AG |
Isolation and identification of antigen- or ligand-specific binding proteins
|
CN102282173A
(zh)
*
|
2008-03-24 |
2011-12-14 |
艾博特生物技术有限公司 |
用于治疗骨丢失的方法和组合物
|
CU23716A1
(es)
|
2008-09-30 |
2011-10-05 |
Ct Ingenieria Genetica Biotech |
Péptido antagonista de la actividad de la interleucina-15
|
UA109633C2
(uk)
|
2008-12-09 |
2015-09-25 |
|
Антитіло людини проти тканинного фактора
|
TW201106972A
(en)
|
2009-07-27 |
2011-03-01 |
Genentech Inc |
Combination treatments
|
CA2772715C
(en)
|
2009-09-02 |
2019-03-26 |
Genentech, Inc. |
Mutant smoothened and methods of using the same
|
AU2010310457B2
(en)
|
2009-10-23 |
2015-07-02 |
Amgen Inc. |
Vial adapter and system
|
ES2565208T3
(es)
|
2009-12-11 |
2016-04-01 |
F. Hoffmann-La Roche Ag |
Anticuerpos anti-VEGF-C y métodos de uso de los mismos
|
KR20190067275A
(ko)
|
2009-12-21 |
2019-06-14 |
제넨테크, 인크. |
항체 제제
|
KR20180037303A
(ko)
|
2010-06-07 |
2018-04-11 |
암젠 인크 |
약물 전달 장치
|
SI2580243T1
(sl)
|
2010-06-09 |
2020-02-28 |
Genmab A/S |
Protitelesa proti humanemu CD38
|
AU2011267106B2
(en)
|
2010-06-15 |
2015-05-14 |
Genmab A/S |
Human antibody drug conjugates against tissue factor
|
AU2011312205B2
(en)
|
2010-10-05 |
2015-08-13 |
Curis, Inc. |
Mutant smoothened and methods of using the same
|
CA2831100C
(en)
|
2011-03-31 |
2020-02-18 |
Mark Dominis Holt |
Vial adapter and system
|
CA2833748C
(en)
|
2011-04-20 |
2019-07-16 |
Amgen Inc. |
Autoinjector apparatus
|
CN102250243B
(zh)
*
|
2011-07-01 |
2013-08-28 |
华绍炳 |
抗白细胞介素-15抗体
|
EP3418295B1
(en)
*
|
2011-07-18 |
2020-09-02 |
IBA GmbH |
Method of reversibly staining a target cell
|
PT3045189T
(pt)
|
2011-10-14 |
2018-07-23 |
Amgen Inc |
Injetor e método de montagem
|
MX2015006343A
(es)
|
2012-11-21 |
2015-10-05 |
Amgen Inc |
Dispositivo de administracion de farmacos.
|
EP3521312B1
(en)
|
2013-02-20 |
2021-04-07 |
Innate Pharma |
A compound that specifically binds to kir3dl2 for use in the treatment of peripheral t cell lymphoma
|
EP3744345B1
(en)
|
2013-03-13 |
2022-02-09 |
F. Hoffmann-La Roche AG |
Antibody formulations
|
AR095399A1
(es)
|
2013-03-13 |
2015-10-14 |
Genentech Inc |
Formulaciones con oxidación reducida, método
|
RU2019137020A
(ru)
|
2013-03-13 |
2021-01-14 |
Дженентек, Инк. |
Составы со сниженным окислением
|
US20140314778A1
(en)
|
2013-03-13 |
2014-10-23 |
Genentech, Inc. |
Formulations with reduced oxidation
|
JP6389236B2
(ja)
|
2013-03-13 |
2018-09-12 |
ジェネンテック, インコーポレイテッド |
酸化還元製剤
|
EP2968760B1
(en)
|
2013-03-15 |
2024-01-03 |
Amgen Inc. |
Drug cassette, autoinjector, and autoinjector system
|
JP6768501B2
(ja)
|
2013-03-15 |
2020-10-14 |
アムゲン・インコーポレーテッド |
薬物カセット、自動注入機、および自動注入機システム
|
RU2718986C2
(ru)
|
2013-03-15 |
2020-04-15 |
Дженентек, Инк. |
Композиции клеточных культур с антиоксидантами и способы получения полипептидов
|
KR102287687B1
(ko)
|
2013-03-22 |
2021-08-06 |
암젠 인크 |
인젝터 및 조립 방법
|
EA201991715A1
(ru)
|
2013-09-27 |
2020-03-31 |
Дженентек, Инк. |
Композиции, содержащие антитело к pdl1
|
EP3501575B1
(en)
|
2013-10-24 |
2021-12-01 |
Amgen Inc. |
Drug delivery system with temperature-sensitive-control
|
JP7086520B2
(ja)
|
2013-10-24 |
2022-06-20 |
アムジエン・インコーポレーテツド |
インジェクター及び組み立ての方法
|
US20150210772A1
(en)
|
2013-12-17 |
2015-07-30 |
Genentech, Inc. |
Methods of treating cancer using pd-1 axis binding antagonists and an anti-cd20 antibody
|
CN106102774A
(zh)
|
2013-12-17 |
2016-11-09 |
豪夫迈·罗氏有限公司 |
包含ox40结合激动剂和pd‑1轴结合拮抗剂的组合疗法
|
BR112016013896A2
(pt)
|
2013-12-17 |
2017-10-10 |
Genentech Inc |
métodos de tratamento de câncer positivo para her2 usando antagonistas de ligação do eixo de pd-1 e anticorpos anti-her2
|
ES2694857T3
(es)
|
2014-02-04 |
2018-12-27 |
Genentech, Inc. |
Smoothened mutante y métodos de uso de la misma
|
US10994112B2
(en)
|
2014-02-05 |
2021-05-04 |
Amgen Inc. |
Drug delivery system with electromagnetic field generator
|
MX2016012779A
(es)
|
2014-03-31 |
2017-04-27 |
Genentech Inc |
Terapia de combinacion con agentes antiangiogénesis y agonistas de unión a ox40.
|
WO2015171777A1
(en)
|
2014-05-07 |
2015-11-12 |
Amgen Inc. |
Autoinjector with shock reducing elements
|
KR20230037063A
(ko)
|
2014-06-03 |
2023-03-15 |
암겐 인코포레이티드 |
제어 가능한 약물 전달 시스템 및 사용 방법
|
EP2963057A1
(en)
|
2014-07-02 |
2016-01-06 |
Calypso Biotech SA |
Antibodies to IL-15
|
MX2017003121A
(es)
|
2014-09-15 |
2017-08-02 |
Genentech Inc |
Formulaciones de anticuerpos.
|
WO2016061220A2
(en)
|
2014-10-14 |
2016-04-21 |
Amgen Inc. |
Drug injection device with visual and audio indicators
|
EA038462B1
(ru)
|
2014-10-23 |
2021-08-31 |
Эмджен Инк. |
Снижение вязкости фармацевтических составов
|
MX2017006320A
(es)
|
2014-11-17 |
2017-08-10 |
Genentech Inc |
Terapia combinada que comprende agonistas de unión de ox40 y antagonistas de unión del eje de pd-1.
|
EP3233159B1
(en)
|
2014-12-19 |
2020-03-04 |
Amgen Inc. |
Drug delivery device with live button or user interface field
|
ES2898469T3
(es)
|
2014-12-19 |
2022-03-07 |
Amgen Inc |
Dispositivo de administración de medicamentos con sensor de proximidad
|
CN107636170A
(zh)
|
2015-02-04 |
2018-01-26 |
健泰科生物技术公司 |
突变型Smoothened及其使用方法
|
EP3556411B1
(en)
|
2015-02-17 |
2021-06-30 |
Amgen Inc. |
Drug delivery device with vacuum assisted securement and/or feedback
|
EP3981450A1
(en)
|
2015-02-27 |
2022-04-13 |
Amgen, Inc |
Drug delivery device having a needle guard mechanism with a tunable threshold of resistance to needle guard movement
|
CN107771076A
(zh)
|
2015-06-17 |
2018-03-06 |
豪夫迈·罗氏有限公司 |
使用pd‑1轴结合拮抗剂和紫杉烷治疗局部晚期或转移性乳腺癌的方法
|
JOP20200312A1
(ar)
|
2015-06-26 |
2017-06-16 |
Novartis Ag |
الأجسام المضادة للعامل xi وطرق الاستخدام
|
TW202340452A
(zh)
|
2015-08-04 |
2023-10-16 |
美商再生元醫藥公司 |
補充牛磺酸之細胞培養基及用法
|
PL3334747T3
(pl)
|
2015-08-13 |
2024-04-02 |
Amgen Inc. |
Naładowana filtracja wgłębna białek wiążących antygen
|
WO2017039786A1
(en)
|
2015-09-02 |
2017-03-09 |
Amgen Inc. |
Syringe assembly adapter for a syringe
|
WO2017100501A1
(en)
|
2015-12-09 |
2017-06-15 |
Amgen Inc. |
Auto-injector with signaling cap
|
SG11201804961UA
(en)
|
2015-12-30 |
2018-07-30 |
Genentech Inc |
Formulations with reduced degradation of polysorbate
|
CN108430455A
(zh)
|
2015-12-30 |
2018-08-21 |
豪夫迈·罗氏有限公司 |
色氨酸衍生物用于蛋白质配制剂的用途
|
US11154661B2
(en)
|
2016-01-06 |
2021-10-26 |
Amgen Inc. |
Auto-injector with signaling electronics
|
PL3400246T3
(pl)
|
2016-01-08 |
2021-03-08 |
F. Hoffmann-La Roche Ag |
Sposoby leczenia nowotworów z dodatnim markerem cea z wykorzystaniem antagonistów wiążących oś pd-1 oraz przeciwciał dwuswoistych anty-cea/anty-cd3
|
CN109071625A
(zh)
|
2016-02-04 |
2018-12-21 |
柯瑞斯公司 |
平滑化突变体和其使用方法
|
EP3429663B1
(en)
|
2016-03-15 |
2020-07-15 |
Amgen Inc. |
Reducing probability of glass breakage in drug delivery devices
|
EP4112641A1
(en)
|
2016-03-15 |
2023-01-04 |
Chugai Seiyaku Kabushiki Kaisha |
Methods of treating cancers using pd-1 axis binding antagonists and anti-gpc3 antibodies
|
US11541168B2
(en)
|
2016-04-29 |
2023-01-03 |
Amgen Inc. |
Drug delivery device with messaging label
|
US11389588B2
(en)
|
2016-05-02 |
2022-07-19 |
Amgen Inc. |
Syringe adapter and guide for filling an on-body injector
|
WO2017197222A1
(en)
|
2016-05-13 |
2017-11-16 |
Amgen Inc. |
Vial sleeve assembly
|
WO2017200989A1
(en)
|
2016-05-16 |
2017-11-23 |
Amgen Inc. |
Data encryption in medical devices with limited computational capability
|
TW201802121A
(zh)
|
2016-05-25 |
2018-01-16 |
諾華公司 |
抗因子XI/XIa抗體之逆轉結合劑及其用途
|
WO2017209899A1
(en)
|
2016-06-03 |
2017-12-07 |
Amgen Inc. |
Impact testing apparatuses and methods for drug delivery devices
|
US20180002417A1
(en)
|
2016-06-15 |
2018-01-04 |
Celimmune Llc |
Methods and Compositions for the Treatment of Celiac Disease, Non-Celiac Gluten Sensitivity, and Refractory Celiac Disease
|
US11285266B2
(en)
|
2016-07-01 |
2022-03-29 |
Amgen Inc. |
Drug delivery device having minimized risk of component fracture upon impact events
|
JP7250674B2
(ja)
|
2016-08-08 |
2023-04-03 |
エフ・ホフマン-ラ・ロシュ・アクチェンゲゼルシャフト |
がんの治療及び診断方法
|
WO2018034784A1
(en)
|
2016-08-17 |
2018-02-22 |
Amgen Inc. |
Drug delivery device with placement detection
|
WO2018067987A1
(en)
|
2016-10-06 |
2018-04-12 |
Amgen Inc. |
Reduced viscosity protein pharmaceutical formulations
|
SG11201903521XA
(en)
|
2016-10-21 |
2019-05-30 |
Amgen Inc |
Pharmaceutical formulations and methods of making the same
|
EP3532127A1
(en)
|
2016-10-25 |
2019-09-04 |
Amgen Inc. |
On-body injector
|
MX2019007357A
(es)
*
|
2016-12-21 |
2019-09-05 |
Cephalon Inc |
Anticuerpos que se unen especificamente a il-15 humana y usos de estos.
|
CN110325550B
(zh)
|
2016-12-23 |
2024-03-08 |
诺华股份有限公司 |
因子xi抗体和使用方法
|
AU2018210301A1
(en)
|
2017-01-17 |
2019-08-01 |
Amgen Inc. |
Injection devices and related methods of use and assembly
|
CA3048520A1
(en)
|
2017-02-17 |
2018-08-23 |
Amgen Inc. |
Drug delivery device with sterile fluid flowpath and related method of assembly
|
MX2019009755A
(es)
|
2017-02-17 |
2019-10-07 |
Amgen Inc |
Mecanismo de insercion para dispositivo de suministro de farmacos.
|
MX2019010544A
(es)
|
2017-03-06 |
2019-10-21 |
Amgen Inc |
Dispositivo de administracion de farmacos con caracteristica de prevencion de la activacion.
|
SG11201908058UA
(en)
|
2017-03-07 |
2019-09-27 |
Amgen Inc |
Needle insertion by overpressure
|
SG11201908062QA
(en)
|
2017-03-09 |
2019-09-27 |
Amgen Inc |
Insertion mechanism for drug delivery device
|
LT3600491T
(lt)
|
2017-03-28 |
2023-10-10 |
Amgen Inc. |
Stūmoklio koto ir švirkšto konstrukcinė sistema ir būdas
|
US11278505B2
(en)
|
2017-04-24 |
2022-03-22 |
University Of Massachusetts |
Diagnosis and treatment of vitiligo
|
EP3615069A1
(en)
|
2017-04-28 |
2020-03-04 |
Amgen Inc. |
N-acetylated and non-acetylated dipeptides containing arginine to reduce the viscosity of viscous compositions of therapeutic polypeptides
|
AU2018280054B2
(en)
|
2017-06-08 |
2023-07-13 |
Amgen Inc. |
Syringe assembly for a drug delivery device and method of assembly
|
AU2018282077B2
(en)
|
2017-06-08 |
2023-11-23 |
Amgen Inc. |
Torque driven drug delivery device
|
US11541183B2
(en)
|
2017-06-22 |
2023-01-03 |
Amgen Inc. |
Device activation impact/shock reduction
|
CA3063921A1
(en)
|
2017-06-23 |
2018-12-27 |
Amgen Inc. |
Electronic drug delivery device comprising a cap activated by a switch assembly
|
JP7408398B2
(ja)
|
2017-07-14 |
2024-01-05 |
アムジエン・インコーポレーテツド |
二重ねじりばねシステムを有する針挿入後退システム
|
JP2020527376A
(ja)
|
2017-07-21 |
2020-09-10 |
アムジエン・インコーポレーテツド |
薬物容器のためのガス透過性シーリング部材及び組立方法
|
EP3658206A1
(en)
|
2017-07-25 |
2020-06-03 |
Amgen Inc. |
Drug delivery device with container access system and related method of assembly
|
EP4085942A1
(en)
|
2017-07-25 |
2022-11-09 |
Amgen Inc. |
Drug delivery device with gear module and related method of assembly
|
WO2019028187A1
(en)
|
2017-08-01 |
2019-02-07 |
Amgen Inc. |
SYSTEMS AND METHODS FOR REAL-TIME PREPARATION OF A POLYPEPTIDE SAMPLE FOR MASS SPECTROMETRY ANALYSIS
|
BR112020001922A2
(pt)
|
2017-08-01 |
2020-08-04 |
Amgen Inc. |
sistemas e métodos para realização de um ensaio de glicanas em tempo real de uma amostra
|
US20200164155A1
(en)
|
2017-08-09 |
2020-05-28 |
Amgen Inc. |
Hydraulic-pneumatic pressurized chamber drug delivery system
|
EP3668567A1
(en)
|
2017-08-18 |
2020-06-24 |
Amgen Inc. |
Wearable injector with sterile adhesive patch
|
US11103636B2
(en)
|
2017-08-22 |
2021-08-31 |
Amgen Inc. |
Needle insertion mechanism for drug delivery device
|
WO2019070472A1
(en)
|
2017-10-04 |
2019-04-11 |
Amgen Inc. |
FLOW ADAPTER FOR MEDICATION DELIVERY DEVICE
|
MA50614A
(fr)
|
2017-10-06 |
2020-08-12 |
Amgen Inc |
Dispositif d'administration de médicament comprenant un ensemble de verrouillage et procédé d'assemblage associé
|
WO2019074579A1
(en)
|
2017-10-09 |
2019-04-18 |
Amgen Inc. |
DRUG DELIVERY DEVICE COMPRISING A DRIVE ASSEMBLY AND ASSEMBLY METHOD THEREOF
|
US11826480B2
(en)
|
2017-11-03 |
2023-11-28 |
Amgen Inc. |
Systems and approaches for sterilizing a drug delivery device
|
US20200338271A1
(en)
|
2017-11-06 |
2020-10-29 |
Amgen Inc. |
Fill-finish assemblies and related methods
|
US20200261648A1
(en)
|
2017-11-06 |
2020-08-20 |
Amgen Inc. |
Drug delivery device with placement and flow sensing
|
AU2018364933B2
(en)
|
2017-11-10 |
2024-01-25 |
Amgen Inc. |
Plungers for drug delivery devices
|
MX2020005066A
(es)
|
2017-11-16 |
2020-08-20 |
Amgen Inc |
Autoinyector con deteccion de detencion y punto final.
|
JP7370969B2
(ja)
|
2017-11-16 |
2023-10-30 |
アムジエン・インコーポレーテツド |
薬物送達デバイスの扉ラッチ機構
|
EP3740264A1
(en)
|
2018-01-17 |
2020-11-25 |
Amgen Inc. |
Drug delivery mechanism
|
MA52268A
(fr)
|
2018-03-07 |
2021-01-13 |
Amgen Inc |
Seringue à distribution contrôlée
|
EP3762067A1
(en)
|
2018-03-09 |
2021-01-13 |
Amgen Inc. |
Backflow prevention mechanism for drug delivery device
|
KR20200131266A
(ko)
|
2018-03-13 |
2020-11-23 |
암젠 인크 |
질량 분광 분석을 위한 폴리펩티드의 순차적 소화
|
JP2021516672A
(ja)
|
2018-03-13 |
2021-07-08 |
アムジエン・インコーポレーテツド |
質量分光測定分析のためのトリプシン耐性ポリペプチドを調製するための方法
|
PL3775857T3
(pl)
|
2018-03-30 |
2024-01-29 |
Amgen Inc. |
Sprawdzanie pojemnika na lek z wykorzystaniem kamery
|
US11583633B2
(en)
|
2018-04-03 |
2023-02-21 |
Amgen Inc. |
Systems and methods for delayed drug delivery
|
US10835685B2
(en)
|
2018-05-30 |
2020-11-17 |
Amgen Inc. |
Thermal spring release mechanism for a drug delivery device
|
US11083840B2
(en)
|
2018-06-01 |
2021-08-10 |
Amgen Inc. |
Modular fluid path assemblies for drug delivery devices
|
CA3103017A1
(en)
|
2018-06-23 |
2019-12-26 |
Genentech, Inc. |
Methods of treating lung cancer with a pd-1 axis binding antagonist, a platinum agent, and a topoisomerase ii inhibitor
|
US20200171146A1
(en)
|
2018-07-18 |
2020-06-04 |
Genentech, Inc. |
Methods of treating lung cancer with a pd-1 axis binding antagonist, an antimetabolite, and a platinum agent
|
CA3103682A1
(en)
|
2018-07-24 |
2020-01-30 |
Amgen Inc. |
Delivery devices for administering drugs
|
WO2020023336A1
(en)
|
2018-07-24 |
2020-01-30 |
Amgen Inc. |
Hybrid drug delivery devices with grip portion
|
MA53379A
(fr)
|
2018-07-24 |
2021-06-02 |
Amgen Inc |
Dispositifs d'administration pour l'administration de médicaments
|
US20210260279A1
(en)
|
2018-07-24 |
2021-08-26 |
Amgen Inc. |
Hybrid drug delivery devices with optional grip portion and related method of preparation
|
EP3829692A1
(en)
|
2018-07-31 |
2021-06-09 |
Amgen Inc. |
Fluid path assembly for a drug delivery device
|
SG11202100601TA
(en)
|
2018-08-08 |
2021-02-25 |
Genentech Inc |
Use of tryptophan derivatives and l-methionine for protein formulation
|
EP3836988A1
(en)
|
2018-08-17 |
2021-06-23 |
Amgen Inc. |
Activation mechanism for drug delivery device
|
KR20210062634A
(ko)
|
2018-09-21 |
2021-05-31 |
제넨테크, 인크. |
3중-음성 유방암에 대한 진단 방법
|
MA53724A
(fr)
|
2018-09-24 |
2021-12-29 |
Amgen Inc |
Systèmes et procédés de dosage interventionnel
|
US20210228811A1
(en)
|
2018-09-28 |
2021-07-29 |
Amgen Inc. |
Muscle wire escapement activation assembly for a drug delivery device
|
CN112805048B
(zh)
|
2018-10-02 |
2023-09-22 |
安进公司 |
具有内部力传递的用于药物递送的注射***
|
MA53818A
(fr)
|
2018-10-05 |
2022-01-12 |
Amgen Inc |
Dispositif d'administration de médicament ayant un indicateur de dose
|
EA202191038A1
(ru)
|
2018-10-15 |
2021-07-06 |
Эмджен Инк. |
Способ платформенной сборки для устройства доставки лекарственного средства
|
EP3866890A1
(en)
|
2018-10-15 |
2021-08-25 |
Amgen Inc. |
Drug delivery device having damping mechanism
|
WO2020091956A1
(en)
|
2018-11-01 |
2020-05-07 |
Amgen Inc. |
Drug delivery devices with partial drug delivery member retraction
|
TWI831847B
(zh)
|
2018-11-01 |
2024-02-11 |
美商安進公司 |
部分針頭縮回之藥物遞送裝置及其操作方法
|
CA3113076A1
(en)
|
2018-11-01 |
2020-05-07 |
Amgen Inc. |
Drug delivery devices with partial drug delivery member retraction
|
US20220146413A1
(en)
|
2018-12-14 |
2022-05-12 |
Amgen Inc. |
System suitability method for use with protein concentration determination by slope
|
US11534547B2
(en)
|
2019-01-24 |
2022-12-27 |
Amgen Inc. |
Drug delivery systems and methods with pressure sensitive control
|
AU2020212547A1
(en)
|
2019-01-24 |
2021-06-10 |
Amgen Inc. |
Drug delivery systems and methods with back pressure sensing
|
EP3924016A1
(en)
|
2019-02-12 |
2021-12-22 |
Amgen Inc. |
Continuous dosing systems and approaches
|
US20200254173A1
(en)
|
2019-02-12 |
2020-08-13 |
Amgen Inc. |
Take-home drug delivery system
|
CA3124134A1
(en)
|
2019-02-12 |
2020-08-20 |
Amgen Inc. |
Continuous dosing systems and approaches
|
CA3124131A1
(en)
|
2019-02-12 |
2020-08-20 |
Amgen Inc. |
Dosing systems and approaches
|
WO2020167910A1
(en)
|
2019-02-12 |
2020-08-20 |
Amgen Inc. |
Systems and approaches for drug delivery device reconstitution
|
US20220062543A1
(en)
|
2019-02-12 |
2022-03-03 |
Amgen Inc. |
Continuous dosing systems and approaches
|
AU2020221372A1
(en)
|
2019-02-14 |
2021-08-19 |
Amgen Inc. |
Systems and methods for preparing a sample and performing a real-time assay of the sample
|
JP2022521200A
(ja)
|
2019-02-20 |
2022-04-06 |
アムジエン・インコーポレーテツド |
タンパク質の安定性を決定する方法
|
CA3130462A1
(en)
|
2019-03-04 |
2020-09-10 |
Amgen Inc. |
In vivo reversibility of high molecular weight species
|
WO2020198538A1
(en)
|
2019-03-27 |
2020-10-01 |
Amgen Inc. |
Methods of fingerprinting therapeutic proteins via a two-dimensional (2d) nuclear magnetic resonance technique at natural abundance for formulated biopharmaceutical products
|
US11464706B2
(en)
|
2019-04-08 |
2022-10-11 |
Amgen Inc. |
Automated drug delivery device and container
|
AU2020271035A1
(en)
|
2019-04-09 |
2021-09-09 |
Amgen Inc. |
Drug delivery device with smart grip
|
AU2020259327A1
(en)
|
2019-04-17 |
2021-09-16 |
Amgen Inc. |
Cassette for an autoinjector and related methods
|
EP3958925A1
(en)
|
2019-04-24 |
2022-03-02 |
Amgen Inc. |
Injector accessories
|
WO2020219482A1
(en)
|
2019-04-24 |
2020-10-29 |
Amgen Inc. |
Syringe sterilization verification assemblies and methods
|
US20220260584A1
(en)
|
2019-06-05 |
2022-08-18 |
Amgen Inc. |
Methods of identifying attributes of therapeutic proteins
|
CN114341189A
(zh)
*
|
2019-06-12 |
2022-04-12 |
奥美药业有限公司 |
全新il-15前药及其应用
|
WO2020257137A1
(en)
|
2019-06-20 |
2020-12-24 |
Amgen Inc. |
Wireless communication enabled drug delivery device and method
|
US20220249778A1
(en)
|
2019-07-18 |
2022-08-11 |
Amgen Inc. |
Sealing arrangement for drug delivery device
|
US20220362474A1
(en)
|
2019-07-18 |
2022-11-17 |
Amgen Inc. |
Drug delivery device having pressurized vessel
|
CA3148032A1
(en)
|
2019-08-01 |
2021-02-04 |
Amgen Inc. |
Drug delivery device with temperature measurement and related method
|
EP4017560A2
(en)
|
2019-08-23 |
2022-06-29 |
Amgen, Inc |
Drug delivery device with configurable needle shield engagement components and related methods
|
JP2022545556A
(ja)
|
2019-09-03 |
2022-10-27 |
アムジエン・インコーポレーテツド |
薬物送達用の起動可能な注入デバイス
|
MX2022002355A
(es)
|
2019-09-03 |
2022-04-06 |
Amgen Inc |
Dispositivo de inyeccion para suministro de farmacos y envase para el dispositivo de inyeccion.
|
WO2021050494A1
(en)
|
2019-09-12 |
2021-03-18 |
Amgen Inc. |
Backflow prevention mechanism for drug delivery device
|
AU2020348947A1
(en)
|
2019-09-16 |
2022-03-10 |
Amgen Inc. |
Method for external sterilization of drug delivery device
|
MX2022003703A
(es)
|
2019-09-30 |
2022-04-26 |
Amgen Inc |
Dispositivo de administracion de farmacos.
|
EP4037733A1
(en)
|
2019-09-30 |
2022-08-10 |
Amgen Inc. |
Drug delivery device
|
MX2022003700A
(es)
|
2019-09-30 |
2022-04-26 |
Amgen Inc |
Dispositivo de administracion de farmacos.
|
BR112022005827A2
(pt)
|
2019-09-30 |
2022-06-21 |
Amgen Inc |
Dispositivo de administração de fármaco e métodos de administração de um fármaco
|
WO2021067989A1
(en)
|
2019-09-30 |
2021-04-08 |
Amgen Inc. |
Drug delivery device
|
CA3155062A1
(en)
|
2019-09-30 |
2021-04-08 |
Amgen Inc. |
Drug delivery device
|
US20220340326A1
(en)
|
2019-10-07 |
2022-10-27 |
Amgen Inc. |
Packages for pharmaceutical products and methods of assembly
|
EP4041347A1
(en)
|
2019-10-07 |
2022-08-17 |
Amgen Inc. |
Drug delivery device with fingerprint sensor
|
EP4041342A1
(en)
|
2019-10-07 |
2022-08-17 |
Amgen Inc. |
Needle insertion mechanism for drug delivery device
|
US11660435B2
(en)
|
2019-10-07 |
2023-05-30 |
Amgen Inc. |
Light-activated ultrasonic delivery and manipulation of liquid medication from a drug reservoir
|
US20240082502A1
(en)
|
2019-10-08 |
2024-03-14 |
Amgen Inc. |
Drug delivery device
|
US20240100247A1
(en)
|
2019-10-08 |
2024-03-28 |
Amgen Inc. |
Needle insertion mechanism for drug delivery device
|
JP2022552184A
(ja)
|
2019-10-08 |
2022-12-15 |
アムジエン・インコーポレーテツド |
薬物送達デバイスの温度表示部
|
AU2020363623A1
(en)
|
2019-10-08 |
2022-03-17 |
Amgen Inc. |
Cassette for an autoinjector and related methods
|
JP2022551738A
(ja)
|
2019-10-18 |
2022-12-13 |
アムジエン・インコーポレーテツド |
薬物送達デバイス再構成のためのシステム及び手法
|
EP4045110A2
(en)
|
2019-10-18 |
2022-08-24 |
Amgen Inc. |
Drug delivery device and system
|
MX2022004488A
(es)
|
2019-10-18 |
2022-05-06 |
Amgen Inc |
Sistemas y enfoques para reconstitucion en dispositivo de administracion de farmacos.
|
US20240066215A1
(en)
|
2019-10-18 |
2024-02-29 |
Amgen Inc. |
Drug delivery device and system
|
EP4048346A1
(en)
|
2019-10-21 |
2022-08-31 |
Amgen Inc. |
Drug product container and drug delivery system
|
US20220387702A1
(en)
|
2019-10-24 |
2022-12-08 |
Amgen Inc. |
Drug delivery device
|
US20220378657A1
(en)
|
2019-10-24 |
2022-12-01 |
Amgen Inc. |
Systems and components for drug delivery and components for preparation of the same
|
WO2021081321A1
(en)
|
2019-10-24 |
2021-04-29 |
Amgen Inc. |
Systems and approaches for drug delivery
|
US20220387700A1
(en)
|
2019-10-24 |
2022-12-08 |
Amgen Inc. |
Systems and methods for drug delivery
|
WO2021081186A1
(en)
|
2019-10-24 |
2021-04-29 |
Amgen Inc. |
Drug delivery device and system
|
WO2021091749A1
(en)
|
2019-11-07 |
2021-05-14 |
Amgen Inc. |
Drug delivery system and method of use
|
EP4069340A1
(en)
|
2019-12-02 |
2022-10-12 |
Amgen Inc. |
Lockout mechanism for drug delivery device
|
US20230347075A1
(en)
|
2019-12-05 |
2023-11-02 |
Amgen Inc. |
Flow restrictor for drug delivery device
|
US20230108562A1
(en)
|
2020-01-11 |
2023-04-06 |
AskGene Pharma, Inc. |
Novel masked cytokines and methods of use thereof
|
BR112022013719A2
(pt)
|
2020-01-13 |
2022-10-11 |
Amgen Inc |
Removedores de proteção de agulha, dispositivos de administração de fármacos e métodos relacionados
|
AU2021226754A1
(en)
|
2020-02-24 |
2022-07-07 |
Amgen Inc. |
Containers and systems for use during external sterilization of drug delivery devices
|
AU2021237384A1
(en)
|
2020-03-16 |
2022-08-25 |
Amgen Inc. |
Drug delivery member insertion sensing assemblies, drug delivery devices, and related methods
|
US20230355895A1
(en)
|
2020-03-17 |
2023-11-09 |
Amgen Inc. |
Controlled dispense syringe
|
EP4143811A1
(en)
|
2020-04-28 |
2023-03-08 |
Amgen Inc. |
Packaging label
|
US20230172808A1
(en)
|
2020-05-22 |
2023-06-08 |
Amgen Inc. |
Storage system and method for storing and transporting medicament
|
CA3181820A1
(en)
|
2020-06-16 |
2021-12-23 |
Genentech, Inc. |
Methods and compositions for treating triple-negative breast cancer
|
JP2023540484A
(ja)
|
2020-09-02 |
2023-09-25 |
アムジエン・インコーポレーテツド |
薬剤保管カートン用の簡易開封装置
|
US20230302264A1
(en)
|
2020-09-09 |
2023-09-28 |
Amgen Inc. |
Swallowable drug delivery devices
|
WO2022055761A1
(en)
|
2020-09-11 |
2022-03-17 |
Amgen Inc. |
Inline uv flow device for sterilizing flow cytometry sheath fluid
|
CA3195365A1
(en)
|
2020-09-18 |
2022-03-24 |
Amgen Inc. |
Methods of processing a sample for peptide mapping analysis
|
JP2023545425A
(ja)
|
2020-10-12 |
2023-10-30 |
アムジエン・インコーポレーテツド |
長期薬剤保管装置及び方法
|
AU2021376245A1
(en)
|
2020-11-04 |
2023-04-13 |
Amgen Inc. |
Drug delivery device assembly and accessory for drug delivery device
|
AU2021373586A1
(en)
|
2020-11-04 |
2023-04-20 |
Amgen Inc. |
Drug delivery device assembly and accessory for drug delivery device
|
MX2023005059A
(es)
|
2020-11-04 |
2023-05-12 |
Amgen Inc |
Ensamblaje de dispositivo de administracion de farmacos y accesorio para dispositivo de administracion de farmacos.
|
AU2021376106A1
(en)
|
2020-11-04 |
2023-04-20 |
Amgen Inc. |
Drug delivery device assembly and accessory for drug delivery device
|
US20240010672A1
(en)
|
2020-11-05 |
2024-01-11 |
Amgen Inc. |
Materials and methods for protein processing
|
US20240103025A1
(en)
|
2021-02-03 |
2024-03-28 |
Amgen Inc. |
Systems and approaches for drug processing
|
WO2022169724A1
(en)
|
2021-02-03 |
2022-08-11 |
Amgen Inc. |
Coaxial needle adapter and guide bracket for robotic liquid handling platform
|
US20240115462A1
(en)
|
2021-02-03 |
2024-04-11 |
Amgen Inc. |
High-throughput automated reconstitution of lyophilized drug product
|
WO2022192100A1
(en)
|
2021-03-08 |
2022-09-15 |
Amgen Inc. |
Manufacturing process for hollow plunger rod
|
TW202302169A
(zh)
|
2021-03-10 |
2023-01-16 |
美商安進公司 |
藥物遞送裝置
|
IL305212A
(en)
|
2021-03-10 |
2023-10-01 |
Amgen Inc |
A drug delivery device with a removable cap
|
US20220288326A1
(en)
|
2021-03-10 |
2022-09-15 |
Amgen Inc. |
Drug delivery device, subassembly for drug delivery device, syringe holder, and method of assembly
|
JP2024510668A
(ja)
|
2021-03-25 |
2024-03-08 |
アムジエン・インコーポレーテツド |
薬物送達デバイス
|
US20240157057A1
(en)
|
2021-03-31 |
2024-05-16 |
Amgen Inc. |
Sound-detection based injection time measurement system for drug delivery devices
|
CA3211664A1
(en)
|
2021-04-22 |
2022-10-27 |
Amgen Inc. |
Methods and systems for automated syringe quality evaluation
|
AU2022266655A1
(en)
|
2021-04-28 |
2023-09-21 |
Amgen Inc. |
Systems for out-patient treatment of a patient, and related methods
|
WO2022245574A1
(en)
|
2021-05-17 |
2022-11-24 |
Amgen Inc. |
Feedback system and method for a drug product
|
CN117320964A
(zh)
|
2021-05-21 |
2023-12-29 |
美国安进公司 |
优化药物容器的灌装方案的方法
|
WO2022256199A1
(en)
|
2021-06-01 |
2022-12-08 |
Amgen Inc. |
Lyophilization system
|
CA3216885A1
(en)
|
2021-06-08 |
2022-12-15 |
Amgen Inc. |
Drug delivery devices, finger-grip elements, and related methods
|
CN117500548A
(zh)
|
2021-06-17 |
2024-02-02 |
美国安进公司 |
具有减震器的药物递送装置
|
AU2022296519A1
(en)
|
2021-06-23 |
2024-01-18 |
Amgen Inc. |
Syringes, assemblies, and methods of manufacture
|
WO2023278125A1
(en)
|
2021-06-28 |
2023-01-05 |
Amgen Inc. |
Safety device for drug delivery system
|
EP4370087A1
(en)
|
2021-07-16 |
2024-05-22 |
Amgen Inc. |
Systems and approaches for drug processing single-use hardware
|
CN117999106A
(zh)
|
2021-09-29 |
2024-05-07 |
美国安进公司 |
用于预填充式注射器中的柱塞-塞子深度测量的设备、***和方法
|
TW202322863A
(zh)
|
2021-10-06 |
2023-06-16 |
美商安進公司 |
用於藥物遞送裝置的衝擊啟動式制動特徵
|
CA3233406A1
(en)
|
2021-10-06 |
2023-04-13 |
Amgen Inc. |
Impact activated retention feature for drug delivery device
|
WO2023064119A1
(en)
|
2021-10-11 |
2023-04-20 |
Amgen Inc. |
Characterization apparatus for drug delivery devices or subcomponents thereof
|
AU2022382741A1
(en)
|
2021-11-05 |
2024-04-04 |
Amgen Inc. |
Drug delivery devices, components for use within drug delivery devices
|
CA3237662A1
(en)
|
2021-11-09 |
2023-05-19 |
Amgen Inc. |
Production of therapeutic proteins
|
AU2022396290A1
(en)
|
2021-11-29 |
2024-04-04 |
Amgen Inc. |
Plunger rod removal force method and fixture
|
TW202335692A
(zh)
|
2021-12-03 |
2023-09-16 |
美商安進公司 |
注射器中的塞子放置
|
WO2023172592A1
(en)
|
2022-03-11 |
2023-09-14 |
Amgen Inc. |
Adjustable depth autoinjector
|
WO2023196111A1
(en)
|
2022-04-06 |
2023-10-12 |
Amgen Inc. |
Packaging for drug delivery device
|
WO2024028448A1
(en)
|
2022-08-04 |
2024-02-08 |
Calypso Biotech Sa |
Il-15 inhibitors useful for the treatment of atopic dermatitis
|
WO2024040020A1
(en)
|
2022-08-15 |
2024-02-22 |
Absci Corporation |
Quantitative affinity activity specific cell enrichment
|
WO2024039575A1
(en)
|
2022-08-18 |
2024-02-22 |
Amgen Inc. |
Needle shield for syringe
|
WO2024039707A1
(en)
|
2022-08-18 |
2024-02-22 |
Amgen Inc. |
Needle shield assembly for a syringe
|
WO2024049793A1
(en)
|
2022-08-30 |
2024-03-07 |
Amgen Inc. |
System and method of limiting subvisible particles in a syringe
|
CN117209605B
(zh)
*
|
2023-11-09 |
2024-01-30 |
北京百普赛斯生物科技股份有限公司 |
特异性结合il-15的抗体及其应用
|